Correction to: Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study. [PDF]
europepmc +1 more source
Safety and Efficacy of Fecal Microbiota, Live-jslm to Prevent Recurrent Clostridioides difficile Infection in Participants With Irritable Bowel Syndrome. [PDF]
Aroniadis OC +6 more
europepmc +1 more source
Impact of the COVID-19 Pandemic on Clostridioides difficile Infection Rates in a Tertiary Hospital: A Retrospective Comparative Study. [PDF]
Shabana H, Abdelwahed H.
europepmc +1 more source
Guiding Clostridioides difficile Infection Prevention Efforts in a Hospital Setting With AI.
Tang S +16 more
europepmc +1 more source
Fecal Metabolomics for the Diagnosis of <i>Clostridioides difficile</i> Infection. [PDF]
Bea-Serrano C +12 more
europepmc +1 more source
The Burden ofClostridioides difficileInfection in Korea
openaire +2 more sources
Citrulline Inhibits Clostridioides difficile Infection With Anti-inflammatory Effects. [PDF]
Xie Y +9 more
europepmc +1 more source
Severe form of an acute schistosomiasis with involvement of the gastrointestinal tract and lungs complicated by Clostridioides difficile infection. [PDF]
Zieliński P +4 more
europepmc +1 more source
Microbiome and Metabolome Restoration After Administration of Fecal Microbiota, Live-jslm (REBYOTA) for Preventing Recurrent Clostridioides difficile Infection. [PDF]
Blount KF +6 more
europepmc +1 more source
Lactiplantibacillus plantarum GMNL-661 Ameliorates Clostridioides difficile Infection and Reconfigures Intestinal Microbiota in a Murine Model. [PDF]
Li MJ +9 more
europepmc +1 more source

